The DOI matches its Crossref record; 331 of the 331 references it cites were found in a registry or an index.
Synthetic Nanoparticles for Vaccines and Immunotherapy
Open accessAbstract
The immune system plays a critical role in our health. No other component of human physiology plays a decisive role in as diverse an array of maladies, from deadly diseases with which we are all familiar to equally terrible esoteric conditions: HIV, malaria, pneumococcal and influenza infections; cancer; atherosclerosis; autoimmune diseases such as lupus, diabetes, and multiple sclerosis. The importance of understanding the function of the immune system and learning how to modulate immunity to protect against or treat disease thus cannot be overstated. Fortunately, we are entering an exciting era where the science of immunology is defining pathways for the rational manipulation of the immune system at the cellular and molecular level, and this understanding is leading to dramatic advances in the clinic that are transforming the future of medicine.1,2 These initial advances are being made primarily through biologic drugs– recombinant proteins (especially antibodies) or patient-derived cell therapies– but exciting data from preclinical studies suggest that a marriage of approaches based in biotechnology with the materials science and chemistry of nanomaterials, especially nanoparticles, could enable more effective and safer immune engineering strategies. This review will examine these nanoparticle-based strategies to immune modulation in detail, and discuss the promise and outstanding challenges facing the field of immune engineering from a chemical biology/materials engineering perspective
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
Hodi, F. S., O'Day, S. J., McDermott, D. F., Weber, R. W., Sosman, J. A., Haanen, J. B., Gonzalez, R., Robert, C., Schadendorf, D., Hassel, J. C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003466 · Cited by 15,155
Dendritic cells and the control of immunity
Banchereau, J., & Steinman, R. M. (1998) · Nature · doi:10.1038/32588 · Cited by 14,336
Safety, activity, and immune correlates of anti–PD-1 antibody in cancer
Topalian, S. L., Hodi, F. S., Brahmer, J. R., Gettinger, S. N., Smith, D. C., McDermott, D. F., Powderly, J. D., Carvajal, R. D., Sosman, J. A., Atkins, M. B., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200690 · Cited by 12,628
Neutrophil recruitment and function in health and inflammation
Kolaczkowska, E., & Kubes, P. (2013) · Nature Reviews Immunology · doi:10.1038/nri3399 · Cited by 5,472
Protective and pathogenic functions of macrophage subsets
Murray, P. J., & Wynn, T. A. (2011) · Nature Reviews Immunology · doi:10.1038/nri3073 · Cited by 5,269
Tolerance, Danger, and the Extended Family
Matzinger, P. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.005015 · Cited by 4,820
The M1 and M2 paradigm of macrophage activation: Time for reassessment
Martinez, F. O., & Gordon, S. (2014) · F1000Prime Reports · doi:10.12703/p6-13 · Cited by 4,689
Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
Snyder, A., Makarov, V., Merghoub, T., Yuan, J., Zaretsky, J. M., Desrichard, A., Walsh, L. A., Postow, M. A., Wong, P., Ho, T. S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1406498 · Cited by 4,286
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233
The Danger Model: A Renewed Sense of Self
Matzinger, P. (2002) · Science · doi:10.1126/science.1071059 · Cited by 4,205
Toll-like receptor control of the adaptive immune responses
Iwasaki, A., & Medzhitov, R. (2004) · Nature Immunology · doi:10.1038/ni1112 · Cited by 4,193
Cancer immunotherapy comes of age
Mellman, I., Coukos, G., & Dranoff, G. (2011) · Nature · doi:10.1038/nature10673 · Cited by 3,893
Toll-like receptors and their crosstalk with other innate receptors in infection and immunity
Kawai, T., & Akira, S. (2011) · Immunity · doi:10.1016/j.immuni.2011.05.006 · Cited by 3,658
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01494-7 · Cited by 3,515
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
Grupp, S. A., Kalos, M., Barrett, D., Aplenc, R., Porter, D. L., Rheingold, S. R., Teachey, D. T., Chew, A., Hauck, B., Wright, J. F., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215134 · Cited by 3,509
Hornung, V., Bauernfeind, F., Halle, A., Samstad, E. O., Kono, H., Rock, K. L., Fitzgerald, K. A., & Latz, E. (2008) · Nature Immunology · doi:10.1038/ni.1631 · Cited by 3,065
Monocyte recruitment during infection and inflammation
Shi, C., & Pamer, E. G. (2011) · Nature Reviews Immunology · doi:10.1038/nri3070 · Cited by 3,015
Exploiting tumour hypoxia in cancer treatment
Brown, J. M., & Wilson, W. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1367 · Cited by 2,828
Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica
Dostert, C., Pétrilli, V., Van Bruggen, R., Steele, C., Mossman, B. T., & Tschopp, J. (2008) · Science · doi:10.1126/science.1156995 · Cited by 2,658
Maeda, H. (2001) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(00)00013-3 · Cited by 2,495
The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles
Fröhlich, E. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s36111 · Cited by 2,484
Applications of nanoparticles in biology and medicine
Salata, O. (2004) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-2-3 · Cited by 2,327
Toxicity of cationic lipids and cationic polymers in gene delivery
Lv, H., Zhang, S., Wang, B., Cui, S., & Yan, J. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.04.014 · Cited by 2,286
Mellman, I., & Steinman, R. M. (2001) · Cell · doi:10.1016/s0092-8674(01)00449-4 · Cited by 2,237
Taking dendritic cells into medicine
Steinman, R. M., & Banchereau, J. (2007) · Nature · doi:10.1038/nature06175 · Cited by 2,127
Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns
Bachmann, M. F., & Jennings, G. T. (2010) · Nature Reviews Immunology · doi:10.1038/nri2868 · Cited by 2,106
Role of target geometry in phagocytosis
Champion, J. A., & Mitragotri, S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600997103 · Cited by 2,074
Couzin-Frankel, J. (2013) · Science · doi:10.1126/science.342.6165.1432 · Cited by 2,051
Autophagy in infection, inflammation and immunity
Deretic, V., Saitoh, T., & Akira, S. (2013) · Nature Reviews Immunology · doi:10.1038/nri3532 · Cited by 1,919
Epidemiology and Prevention of Vaccine-Preventable Diseases
Atkinson, W. W. (2009) · Cited by 1,862
Adoptive immunotherapy for cancer: harnessing the T cell response
Restifo, N. P., Dudley, M. E., & Rosenberg, S. A. (2012) · Nature Reviews Immunology · doi:10.1038/nri3191 · Cited by 1,688
Cross-presentation by dendritic cells
Joffre, O. P., Segura, E., Savina, A., & Amigorena, S. (2012) · Nature Reviews Immunology · doi:10.1038/nri3254 · Cited by 1,637
Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants
Eisenbarth, S. C., Colegio, O. R., O’Connor, W., Sutterwala, F. S., & Flavell, R. A. (2008) · Nature · doi:10.1038/nature06939 · Cited by 1,542
Cancer Cell Membrane-Coated Nanoparticles for Anticancer Vaccination and Drug Delivery
Fang, R. H., Hu, C.-M. J., Luk, B. T., Gao, W., Copp, J. A., Tai, Y., O’Connor, D. E., & Zhang, L. (2014) · Nano Letters · doi:10.1021/nl500618u · Cited by 1,501
In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice
Liu, Z., Cai, W., He, L., Nakayama, N., Chen, K., Sun, X., Chen, X., & Dai, H. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2006.170 · Cited by 1,436
Exploiting lymphatic transport and complement activation in nanoparticle vaccines
Reddy, S. T., van der Vlies, A. J., Simeoni, E., Angeli, V., Randolph, G. J., O'Neil, C. P., Lee, L. K., Swartz, M. A., & Hubbell, J. A. (2007) · Nature Biotechnology · doi:10.1038/nbt1332 · Cited by 1,350
Nanoparticles target distinct dendritic cell populations according to their size
Manolova, V., Flace, A., Bauer, M., Schwarz, K., Saudan, P., & Bachmann, M. F. (2008) · European Journal of Immunology · doi:10.1002/eji.200737984 · Cited by 1,289
Movahedi, K., Laoui, D., Gysemans, C., Baeten, M., Stangé, G., Van den Bossche, J., Mack, M., Pipeleers, D., In't Veld, P., De Baetselier, P., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4672 · Cited by 1,239
Seong, S.-Y., & Matzinger, P. (2004) · Nature Reviews Immunology · doi:10.1038/nri1372 · Cited by 1,220
In vivo Biodistribution and Highly Efficient Tumour Targeting of Carbon Nanotubes in Mice
Liu, Z., Cai, W., He, L., Nakayama, N., Chen, K., Sun, X., Chen, X., & Dai, H. (2020) · Nano-Enabled Medical Applications · doi:10.1201/9780429399039-14 · Cited by 1,213
Yee, C., Thompson, J. A., Byrd, D., Riddell, S. R., Roche, P., Celis, E., & Greenberg, P. D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242600099 · Cited by 1,206
Danger signals: SOS to the immune system
Gallucci, S., & Matzinger, P. (2001) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00191-6 · Cited by 1,204
Napolitani, G., Rinaldi, A., Bertoni, F., Sallusto, F., & Lanzavecchia, A. (2005) · Nature Immunology · doi:10.1038/ni1223 · Cited by 1,157
Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus
Lai, S. K., O'Hanlon, D. E., Harrold, S., Man, S. T., Wang, Y.-Y., Cone, R., & Hanes, J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608611104 · Cited by 1,050
Regulation of Phagosome Maturation by Signals from Toll-Like Receptors
Blander, J. M., & Medzhitov, R. (2004) · Science · doi:10.1126/science.1096158 · Cited by 991
Programming the magnitude and persistence of antibody responses with innate immunity
Kasturi, S. P., Skountzou, I., Albrecht, R. A., Koutsonanos, D., Hua, T., Nakaya, H. I., Ravindran, R., Stewart, S., Alam, M., Kwissa, M., et al. (2011) · Nature · doi:10.1038/nature09737 · Cited by 975
Sarma, J. V., & Ward, P. A. (2011) · Cell and Tissue Research · doi:10.1007/s00441-010-1034-0 · Cited by 974
Structure-based programming of lymph-node targeting in molecular vaccines
Liu, H., Moynihan, K. D., Zheng, Y., Szeto, G. L., Li, A. V., Huang, B., Van Egeren, D. S., Park, C., & Irvine, D. J. (2014) · Nature · doi:10.1038/nature12978 · Cited by 943
Self-citationGastrointestinal Uptake of Biodegradable Microparticles: Effect of Particle Size
Desai, M. P., Labhasetwar, V., Amidon, G. L., & Levy, R. J. (1996) · Pharmaceutical Research · doi:10.1023/a:1016085108889 · Cited by 941
Role of Particle Size in Phagocytosis of Polymeric Microspheres
Champion, J. A., Walker, A., & Mitragotri, S. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9562-y · Cited by 888
A Phagosome-to-Cytosol Pathway for Exogenous Antigens Presented on MHC Class I Molecules
Kovacsovics-Bankowski, M., & Rock, K. L. (1995) · Science · doi:10.1126/science.7809629 · Cited by 884
Chitosan-based gastrointestinal delivery systems
Hejazi, R., & Amiji, M. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00126-3 · Cited by 882
Junt, T., Moseman, E. A., Iannacone, M., Massberg, S., Lang, P. A., Boes, M., Fink, K., Henrickson, S. E., Shayakhmetov, D. M., Di Paolo, N. C., et al. (2007) · Nature · doi:10.1038/nature06287 · Cited by 846
Toll-dependent selection of microbial antigens for presentation by dendritic cells
Blander, J. M., & Medzhitov, R. (2006) · Nature · doi:10.1038/nature04596 · Cited by 840
Therapeutic siRNA silencing in inflammatory monocytes in mice
Leuschner, F., Dutta, P., Gorbatov, R., Novobrantseva, T. I., Donahoe, J. S., Courties, G., Lee, K. M., Kim, J. I., Markmann, J. F., Marinelli, B., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1989 · Cited by 839
Leonard, J. P., Sherman, M. L., Fisher, G. L., Buchanan, L. J., Larsen, G., Atkins, M. B., Sosman, J. A., Dutcher, J. P., Vogelzang, N. J., & Ryan, J. L. (1997) · PubMed · Cited by 820
Benson, D. M., Bakan, C. E., Mishra, A., Hofmeister, C. C., Efebera, Y., Becknell, B., Baiocchi, R. A., Zhang, J., Yu, J., Smith, M. K., et al. (2010) · Blood · doi:10.1182/blood-2010-02-271874 · Cited by 807
Walter, S., Weinschenk, T., Stenzl, A., Zdrojowy, R., Pluzanska, A., Szczylik, C., Staehler, M., Brugger, W., Dietrich, P.-Y., Mendrzyk, R., et al. (2012) · Nature Medicine · doi:10.1038/nm.2883 · Cited by 788
Applications of nanotechnology for immunology
Smith, D. M., Simon, J. K., & Baker Jr, J. R. (2013) · Nature Reviews Immunology · doi:10.1038/nri3488 · Cited by 767
Neutrophil function in inflammation and inflammatory diseases
Wright, H. L., Moots, R. J., Bucknall, R. C., & Edwards, S. W. (2010) · Rheumatology · doi:10.1093/rheumatology/keq045 · Cited by 761
Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR–induced stop signal
Fife, B. T., Pauken, K. E., Eagar, T. N., Obu, T., Wu, J., Tang, Q., Azuma, M., Krummel, M. F., & Bluestone, J. A. (2009) · Nature Immunology · doi:10.1038/ni.1790 · Cited by 759
T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment
Crespo, J., Sun, H., Welling, T. H., Tian, Z., & Zou, W. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2012.12.003 · Cited by 752
Control of B-cell responses by Toll-like receptors
Pasare, C., & Medzhitov, R. (2005) · Nature · doi:10.1038/nature04267 · Cited by 752
Therapeutic cell engineering with surface-conjugated synthetic nanoparticles
Stephan, M. T., Moon, J. J., Um, S. H., Bershteyn, A., & Irvine, D. J. (2010) · Nature Medicine · doi:10.1038/nm.2198 · Cited by 750
Self-citationSynergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function
Zeng, R., Spolski, R., Finkelstein, S. E., Oh, S., Kovanen, P. E., Hinrichs, C. S., Pise-Masison, C. A., Radonovich, M. F., Brady, J. N., Restifo, N. P., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041057 · Cited by 727
Microfold (M) cells: important immunosurveillance posts in the intestinal epithelium
Mabbott, N. A., Donaldson, D. S., Ohno, H., Williams, I. R., & Mahajan, A. (2013) · Mucosal Immunology · doi:10.1038/mi.2013.30 · Cited by 721
The PD-1–PD-L pathway in immunological tolerance
Okazaki, T., & Honjo, T. (2006) · Trends in Immunology · doi:10.1016/j.it.2006.02.001 · Cited by 721
The Influence of Antigen Organization on B Cell Responsiveness
Bachmann, M. F., Rohrer, U. H., Kündig, T. M., Bürki, K., Hengartner, H., & Zinkernagel, R. M. (1993) · Science · doi:10.1126/science.8248784 · Cited by 717
In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles
Reddy, S. T., Rehor, A., Schmoekel, H. G., Hubbell, J. A., & Swartz, M. A. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.01.006 · Cited by 679
Tolerance and exhaustion: defining mechanisms of T cell dysfunction
Schietinger, A., & Greenberg, P. D. (2014) · Trends in Immunology · doi:10.1016/j.it.2013.10.001 · Cited by 673
Size-Dependent Immunogenicity: Therapeutic and Protective Properties of Nano-Vaccines against Tumors
Fifis, T., Gamvrellis, A., Crimeen-Irwin, B., Pietersz, G. A., Li, J., Mottram, P. L., McKenzie, I. F. C., & Plebanski, M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.5.3148 · Cited by 664
Subcapsular encounter and complement-dependent transport of immune complexes by lymph node B cells
Phan, T. G., Grigorova, I., Okada, T., & Cyster, J. G. (2007) · Nature Immunology · doi:10.1038/ni1494 · Cited by 656
Niikura, K., Matsunaga, T., Suzuki, T., Kobayashi, S., Yamaguchi, H., Orba, Y., Kawaguchi, A., Hasegawa, H., Kajino, K., Ninomiya, T., et al. (2013) · ACS Nano · doi:10.1021/nn3057005 · Cited by 638
Carrasco, Y. R., & Batista, F. D. (2007) · Immunity · doi:10.1016/j.immuni.2007.06.007 · Cited by 617
Global Conservation Priorities for Marine Turtles
Wallace, B. P., DiMatteo, A. D., Bolten, A. B., Chaloupka, M. Y., Hutchinson, B. J., Abreu-Grobois, F. A., Mortimer, J. A., Seminoff, J. A., Amorocho, D., Bjorndal, K. A., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024510 · Cited by 617
Kool, M., Pétrilli, V., De Smedt, T., Rolaz, A., Hammad, H., van Nimwegen, M., Bergen, I. M., Castillo, R., Lambrecht, B. N., & Tschopp, J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.6.3755 · Cited by 611
Wang, Y., Lai, S. K., Suk, J. S., Pace, A., Cone, R., & Hanes, J. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200803526 · Cited by 597
Lipid nanocapsules: A new platform for nanomedicine
Huynh, N. T., Passirani, C., Saulnier, P., & Benoit, J. P. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.04.026 · Cited by 595
Engineering synthetic vaccines using cues from natural immunity
Irvine, D. J., Swartz, M. A., & Szeto, G. L. (2013) · Nature Materials · doi:10.1038/nmat3775 · Cited by 594
Self-citationKovacsovics-Bankowski, M., Clark, K., Benacerraf, B., & Rock, K. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.11.4942 · Cited by 591
Enhancement of Nasal Absorption of Insulin Using Chitosan Nanoparticles
Fernández-Urrusuno, R., Calvo, P., Remuñán-López, C., Vila-Jato, J. L., & José Alonso, M. (1999) · Pharmaceutical Research · doi:10.1023/a:1018908705446 · Cited by 587
T-Cell Tolerance: Central and Peripheral
Xing, Y., & Hogquist, K. A. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a006957 · Cited by 576
Moon, J. J., Suh, H., Bershteyn, A., Stephan, M. T., Liu, H., Huang, B., Sohail, M., Luo, S., Ho Um, S., Khant, H., et al. (2011) · Nature Materials · doi:10.1038/nmat2960 · Cited by 564
Self-citationSelf-assembly of self-limiting monodisperse supraparticles from polydisperse nanoparticles
Xia, Y., Nguyen, T. D., Yang, M., Lee, B., Santos, A., Podsiadlo, P., Tang, Z., Glotzer, S. C., & Kotov, N. A. (2011) · Nature Nanotechnology · doi:10.1038/nnano.2011.121 · Cited by 559
Oyewumi, M. O., Kumar, A., & Cui, Z. (2010) · Expert Review of Vaccines · doi:10.1586/erv.10.89 · Cited by 547
Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome
Sharp, F. A., Ruane, D., Claass, B., Creagh, E., Harris, J., Malyala, P., Singh, M., O'Hagan, D. T., Pétrilli, V., Tschopp, J., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804897106 · Cited by 540
Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases
Beeton, C., Wulff, H., Standifer, N. E., Azam, P., Mullen, K. M., Pennington, M. W., Kolski-Andreaco, A., Wei, E., Grino, A., Counts, D. R., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605136103 · Cited by 538
Iwasaki, A. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141634 · Cited by 534
Park, J., Wrzesinski, S. H., Stern, E., Look, M., Criscione, J., Ragheb, R., Jay, S. M., Demento, S. L., Agawu, A., Licona Limon, P., et al. (2012) · Nature Materials · doi:10.1038/nmat3355 · Cited by 494
Construction and Characterization of Virus-Like Particles: A Review
Zeltins, A. (2013) · Molecular Biotechnology · doi:10.1007/s12033-012-9598-4 · Cited by 478
Nanoparticle Hydrophobicity Dictates Immune Response
Moyano, D. F., Goldsmith, M., Solfiell, D. J., Landesman-Milo, D., Miranda, O. R., Peer, D., & Rotello, V. M. (2012) · Journal of the American Chemical Society · doi:10.1021/ja2108905 · Cited by 478
Cario, E., Gerken, G., & Podolsky, D. K. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.04.015 · Cited by 475
Induction of secretory immunity and memory at mucosal surfaces
Brandtzaeg, P. (2007) · Vaccine · doi:10.1016/j.vaccine.2006.12.001 · Cited by 472
Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines
Nochi, T., Yuki, Y., Takahashi, H., Sawada, S.-I., Mejima, M., Kohda, T., Harada, N., Kong, I. G., Sato, A., Kataoka, N., et al. (2010) · Nature Materials · doi:10.1038/nmat2784 · Cited by 468
Modern Subunit Vaccines: Development, Components, and Research Opportunities
Moyle, P. M., & Toth, I. (2013) · ChemMedChem · doi:10.1002/cmdc.201200487 · Cited by 464
Franchi, L., & Núñez, G. (2008) · European Journal of Immunology · doi:10.1002/eji.200838549 · Cited by 450
Resident memory T cells in human health and disease
Clark, R. A. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.3010641 · Cited by 446
Duivenvoorden, R., Tang, J., Cormode, D. P., Mieszawska, A. J., Izquierdo-Garcia, D., Ozcan, C., Otten, M. J., Zaidi, N., Lobatto, M. E., van Rijs, S. M., et al. (2014) · Nature Communications · doi:10.1038/ncomms4065 · Cited by 442
Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance
Maldonado, R. A., LaMothe, R. A., Ferrari, J. D., Zhang, A.-H., Rossi, R. J., Kolte, P. N., Griset, A. P., O’Neil, C., Altreuter, D. H., Browning, E., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1408686111 · Cited by 441
DNA assembly of nanoparticle superstructures for controlled biological delivery and elimination
Chou, L. Y. T., Zagorovsky, K., & Chan, W. C. W. (2014) · Nature Nanotechnology · doi:10.1038/nnano.2013.309 · Cited by 428
Shen, H., Ackerman, A. L., Cody, V., Giodini, A., Hinson, E. R., Cresswell, P., Edelson, R. L., Saltzman, W. M., & Hanlon, D. J. (2006) · Immunology · doi:10.1111/j.1365-2567.2005.02268.x · Cited by 420
New adjuvants for human vaccines
Mbow, M. L., De Gregorio, E., Valiante, N. M., & Rappuoli, R. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.04.004 · Cited by 406
Stealth PLA-PEG nanoparticles as protein carriers for nasal administration
Tobío, M., Gref, R., Sánchez, A., Langer, R., & Alonso, M. J. (1998) · Pharmaceutical Research · doi:10.1023/a:1011922819926 · Cited by 402
Immunoglobulin Responses at the Mucosal Interface
Cerutti, A., Chen, K., & Chorny, A. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101317 · Cited by 395
McKee, A. S., Munks, M. W., MacLeod, M. K. L., Fleenor, C. J., Van Rooijen, N., Kappler, J. W., & Marrack, P. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900164 · Cited by 392
Improved Survival with T Cell Clonotype Stability After Anti–CTLA-4 Treatment in Cancer Patients
Cha, E., Klinger, M., Hou, Y., Cummings, C., Ribas, A., Faham, M., & Fong, L. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008211 · Cited by 383
Harding, C. V., & Song, R. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.11.4925 · Cited by 383
Molecular determinants of immunogenicity: the immunon model of immune response.
Dintzis, H. M., Dintzis, R. Z., & Vogelstein, B. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.10.3671 · Cited by 383
Nanoparticulate STING agonists are potent lymph node–targeted vaccine adjuvants
Hanson, M. C., Crespo, M. P., Abraham, W., Moynihan, K. D., Szeto, G. L., Chen, S. H., Melo, M. B., Mueller, S., & Irvine, D. J. (2015) · Journal of Clinical Investigation · doi:10.1172/jci79915 · Cited by 381
Self-citationLymphatic uptake and biodistribution of liposomes after subcutaneous injection.
Oussoren, C., Zuidema, J., Crommelin, D. J. A., & Storm, G. (1997) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(97)00122-3 · Cited by 380
Mechanism and consequence of chitosan-mediated reversible epithelial tight junction opening
Yeh, T.-H., Hsu, L.-W., Tseng, M. T., Lee, P.-L., Sonjae, K., Ho, Y.-C., & Sung, H.-W. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.03.056 · Cited by 379
de Zoete, M. R., Palm, N. W., Zhu, S., & Flavell, R. A. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016287 · Cited by 379
Mucus-Penetrating Nanoparticles for Vaginal Drug Delivery Protect Against Herpes Simplex Virus
Ensign, L. M., Tang, B. C., Wang, Y.-Y., Tse, T. A., Hoen, T., Cone, R., & Hanes, J. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003453 · Cited by 368
Nucleic Acid Aptamers: Clinical Applications and Promising New Horizons
Ni, X., Castanares, M., Mukherjee, A., & Lupold, S. E. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711797189600 · Cited by 349
Bagchi, A., Herrup, E. A., Warren, H. S., Trigilio, J., Shin, H.-S., Valentine, C., & Hellman, J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.2.1164 · Cited by 347
Li, H., Li, Y., Jiao, J., & Hu, H.-M. (2011) · Nature Nanotechnology · doi:10.1038/nnano.2011.153 · Cited by 347
Robust immune responses elicited by a fully synthetic three-component vaccine
Ingale, S., Wolfert, M. A., Gaekwad, J., Buskas, T., & Boons, G.-J. (2007) · Nature Chemical Biology · doi:10.1038/nchembio.2007.25 · Cited by 337
Watson, D. S., Endsley, A. N., & Huang, L. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.01.070 · Cited by 322
Surface-Engineered Gold Nanorods: Promising DNA Vaccine Adjuvant for HIV-1 Treatment
Xu, L., Liu, Y., Chen, Z., Li, W., Liu, Y., Wang, L., Liu, Y., Wu, X., Ji, Y., Zhao, Y., et al. (2012) · Nano Letters · doi:10.1021/nl300027p · Cited by 320
Fate of polymeric nanocarriers for oral drug delivery
Plapied, L., Duhem, N., des Rieux, A., & Préat, V. (2011) · Current Opinion in Colloid & Interface Science · doi:10.1016/j.cocis.2010.12.005 · Cited by 320
Maisel, K., Ensign, L., Reddy, M., Cone, R., & Hanes, J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.10.026 · Cited by 319
Wilson, J. T., Keller, S., Manganiello, M. J., Cheng, C., Lee, C.-C., Opara, C., Convertine, A., & Stayton, P. S. (2013) · ACS Nano · doi:10.1021/nn305466z · Cited by 317
Role of 4-1BB in immune responses
Vinay, D. S., & Kwon, B. S. (1998) · Seminars in Immunology · doi:10.1006/smim.1998.0157 · Cited by 312
Moon, J. J., Suh, H., Li, A. V., Ockenhouse, C. F., Yadava, A., & Irvine, D. J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1112648109 · Cited by 312
Self-citationMultivalent 4-1BB binding aptamers costimulate CD8+ T cells and inhibit tumor growth in mice
McNamara, J. O., Kolonias, D., Pastor, F., Mittler, R. S., Chen, L., Giangrande, P. H., Sullenger, B., & Gilboa, E. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33365 · Cited by 310
Reversal of Autoimmunity by Boosting Memory-like Autoregulatory T Cells
Tsai, S., Shameli, A., Yamanouchi, J., Clemente-Casares, X., Wang, J., Serra, P., Yang, Y., Medarova, Z., Moore, A., & Santamaria, P. (2010) · Immunity · doi:10.1016/j.immuni.2010.03.015 · Cited by 309
Acetalated dextran is a chemically and biologically tunable material for particulate immunotherapy
Broaders, K. E., Cohen, J. A., Beaudette, T. T., Bachelder, E. M., & Fréchet, J. M. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901592106 · Cited by 308
Hu, Y., Litwin, T., Nagaraja, A. R., Kwong, B., Katz, J., Watson, N., & Irvine, D. J. (2007) · Nano Letters · doi:10.1021/nl071542i · Cited by 305
Self-citationRole of sustained antigen release from nanoparticle vaccines in shaping the T cell memory phenotype
Demento, S. L., Cui, W., Criscione, J. M., Stern, E., Tulipan, J., Kaech, S. M., & Fahmy, T. M. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.03.041 · Cited by 304
Yeste, A., Nadeau, M., Burns, E. J., Weiner, H. L., & Quintana, F. J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120611109 · Cited by 302
Hunter, Z., McCarthy, D. P., Yap, W. T., Harp, C. T., Getts, D. R., Shea, L. D., & Miller, S. D. (2014) · ACS Nano · doi:10.1021/nn405033r · Cited by 301
Prevention of vascular inflammation by nanoparticle targeting of adherent neutrophils
Wang, Z., Li, J., Cho, J., & Malik, A. B. (2014) · Nature Nanotechnology · doi:10.1038/nnano.2014.17 · Cited by 300
Gerner, M. Y., Torabi-Parizi, P., & Germain, R. N. (2015) · Immunity · doi:10.1016/j.immuni.2014.12.024 · Cited by 299
Reis e Sousa, C., & Germain, R. N. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.3.841 · Cited by 296
Role of aluminum-containing adjuvants in antigen internalization by dendritic cells in vitro
Morefield, G. L., Sokolovska, A., Jiang, D., HogenEsch, H., Robinson, J. P., & Hem, S. L. (2005) · Vaccine · doi:10.1016/j.vaccine.2004.07.050 · Cited by 293
Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy
Demento, S. L., Eisenbarth, S. C., Foellmer, H. G., Platt, C., Caplan, M. J., Mark Saltzman, W., Mellman, I., Ledizet, M., Fikrig, E., Flavell, R. A., et al. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.03.034 · Cited by 290
Rancan, F., Gao, Q., Graf, C., Troppens, S., Hadam, S., Hackbarth, S., Kembuan, C., Blume-Peytavi, U., Rühl, E., Lademann, J., et al. (2012) · ACS Nano · doi:10.1021/nn301622h · Cited by 288
Hamad, I., Al-Hanbali, O., Hunter, A. C., Rutt, K. J., Andresen, T. L., & Moghimi, S. M. (2010) · ACS Nano · doi:10.1021/nn101990a · Cited by 276
A 2020 vision for vaccines against HIV, tuberculosis and malaria
Rappuoli, R., & Aderem, A. (2011) · Nature · doi:10.1038/nature10124 · Cited by 273
Okada, E., Sasaki, S., Ishii, N., et al. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.7.3638 · Cited by 272
Therapeutic cancer vaccines: Are we there yet?
Klebanoff, C. A., Acquavella, N., Yu, Z., & Restifo, N. P. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00979.x · Cited by 271
Epithelial Cells in the Female Reproductive Tract: a Central Role as Sentinels of Immune Protection
Wira, C. R., Grant‐Tschudy, K. S., & Crane‐Godreau, M. A. (2005) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2004.00248.x · Cited by 270
Rosalia, R. A., Cruz, L. J., van Duikeren, S., Tromp, A. T., Silva, A. L., Jiskoot, W., de Gruijl, T., Löwik, C., Oostendorp, J., van der Burg, S. H., et al. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2014.10.053 · Cited by 269
Adoptive Immunotherapy for Cancer or Viruses
Maus, M. V., Fraietta, J. A., Levine, B. L., Kalos, M., Zhao, Y., & June, C. H. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120136 · Cited by 264
Contributions of humoral and cellular immunity to vaccine-induced protection in humans
Amanna, I. J., & Slifka, M. K. (2011) · Virology · doi:10.1016/j.virol.2010.12.016 · Cited by 263
Sun, B., Ji, Z., Liao, Y.-P., Wang, M., Wang, X., Dong, J., Chang, C. H., Li, R., Zhang, H., Nel, A. E., et al. (2013) · ACS Nano · doi:10.1021/nn404211j · Cited by 262
Regional and mucosal memory T cells
Sheridan, B. S., & Lefrançois, L. (2011) · Nature Immunology · doi:10.1038/ni.2029 · Cited by 257
Chang, L.-J., Dowd, K. A., Mendoza, F. H., Saunders, J. G., Sitar, S., Plummer, S. H., Yamshchikov, G., Sarwar, U. N., Hu, Z., Enama, M. E., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61185-5 · Cited by 257
de Titta, A., Ballester, M., Julier, Z., Nembrini, C., Jeanbart, L., van der Vlies, A. J., Swartz, M. A., & Hubbell, J. A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1313152110 · Cited by 254
Development of a macrophage-based nanoparticle platform for antiretroviral drug delivery
Dou, H., Destache, C. J., Morehead, J. R., Mosley, R. L., Boska, M. D., Kingsley, J., Gorantla, S., Poluektova, L., Nelson, J. A., Chaubal, M., et al. (2006) · Blood · doi:10.1182/blood-2006-03-012534 · Cited by 253
Hamdy, S., Molavi, O., Ma, Z., Haddadi, A., Alshamsan, A., Gobti, Z., Elhasi, S., Samuel, J., & Lavasanifar, A. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.07.035 · Cited by 252
Chackerian, B., Lowy, D. R., & Schiller, J. T. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11849 · Cited by 251
Liposome-encapsulated antigens are processed in lysosomes, recycled, and presented to T cells
Harding, C. V., Collins, D. S., Slot, J. W., Geuze, H. J., & Unanue, E. R. (1991) · Cell · doi:10.1016/0092-8674(91)90647-h · Cited by 250
Intracellular mechanisms of antigen cross presentation in dendritic cells
Amigorena, S., & Savina, A. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.01.022 · Cited by 247
Jewell, C. M., Bustamante López, S. C., & Irvine, D. J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105200108 · Cited by 245
Self-citationThe Emerging Toxicity Profiles of Anti–CTLA-4 Antibodies Across Clinical Indications
Di Giacomo, A. M., Biagioli, M., & Maio, M. (2010) · Seminars in Oncology · doi:10.1053/j.seminoncol.2010.09.007 · Cited by 245
Smith, B. R., Ghosn, E. E. B., Rallapalli, H., Prescher, J. A., Larson, T., Herzenberg, L. A., & Gambhir, S. S. (2014) · Nature Nanotechnology · doi:10.1038/nnano.2014.62 · Cited by 237
Dou, H., Grotepas, C. B., McMillan, J. M., Destache, C. J., Chaubal, M., Werling, J., Kipp, J., Rabinow, B., & Gendelman, H. E. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900274 · Cited by 237
Perica, K., Tu, A., Richter, A., Bieler, J. G., Edidin, M., & Schneck, J. P. (2014) · ACS Nano · doi:10.1021/nn405520d · Cited by 236
Cruz, L. J., Rosalia, R. A., Kleinovink, J. W., Rueda, F., Löwik, C. W. G. M., & Ossendorp, F. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.07.040 · Cited by 235
Yuan, H., Chen, C.-Y., Chai, G.-H., Du, Y.-Z., & Hu, F.-Q. (2013) · Molecular Pharmaceutics · doi:10.1021/mp300649z · Cited by 234
Hirosue, S., Kourtis, I. C., van der Vlies, A. J., Hubbell, J. A., & Swartz, M. A. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.09.077 · Cited by 233
Zhang, Z., Tongchusak, S., Mizukami, Y., Kang, Y. J., Ioji, T., Touma, M., Reinhold, B., Keskin, D. B., Reinherz, E. L., & Sasada, T. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.01.067 · Cited by 228
Vaccine Activation of the Nutrient Sensor GCN2 in Dendritic Cells Enhances Antigen Presentation
Ravindran, R., Khan, N., Nakaya, H. I., Li, S., Loebbermann, J., Maddur, M. S., Park, Y., Jones, D. P., Chappert, P., Davoust, J., et al. (2014) · Science · doi:10.1126/science.1246829 · Cited by 221
Concepts and practices used to develop functional PLGA-based nanoparticulate systems
Sah, H., Desu, Sah, Wood, & Thoma (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s40579 · Cited by 217
Use of macrophages to deliver therapeutic and imaging contrast agents to tumors
Choi, J., Kim, H.-Y., Ju, E. J., Jung, J., Park, J., Chung, H.-K., Lee, J. S., Lee, J. S., Park, H. J., Song, S. Y., et al. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.02.022 · Cited by 215
Development and in vivo efficacy of targeted polymeric inflammation-resolving nanoparticles
Kamaly, N., Fredman, G., Subramanian, M., Gadde, S., Pesic, A., Cheung, L., Fayad, Z. A., Langer, R., Tabas, I., & Cameron Farokhzad, O. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303377110 · Cited by 214
Lipid tail protrusions mediate the insertion of nanoparticles into model cell membranes
Van Lehn, R. C., Ricci, M., Silva, P. H. J., Andreozzi, P., Reguera, J., Voïtchovsky, K., Stellacci, F., & Alexander-Katz, A. (2014) · Nature Communications · doi:10.1038/ncomms5482 · Cited by 213
Phagosome Maturation Proceeds Independently of Stimulation of Toll-like Receptors 2 and 4
Yates, R. M., & Russell, D. G. (2005) · Immunity · doi:10.1016/j.immuni.2005.09.007 · Cited by 213
Synapse-directed delivery of immunomodulators using T-cell-conjugated nanoparticles
Stephan, M. T., Stephan, S. B., Bak, P., Chen, J., & Irvine, D. J. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.04.029 · Cited by 209
Self-citationInteraction of dendritic cells with antigen-containing liposomes: effect of bilayer composition
Foged, C., Arigita, C., Sundblad, A., Jiskoot, W., Storm, G., & Frokjaer, S. (2004) · Vaccine · doi:10.1016/j.vaccine.2003.11.008 · Cited by 206
Villa, C. H., Dao, T., Ahearn, I., Fehrenbacher, N., Casey, E., Rey, D. A., Korontsvit, T., Zakhaleva, V., Batt, C. A., Philips, M. R., et al. (2011) · ACS Nano · doi:10.1021/nn200182x · Cited by 205
Stefanick, J. F., Ashley, J. D., Kiziltepe, T., & Bilgicer, B. (2013) · ACS Nano · doi:10.1021/nn305663e · Cited by 205
Black, M., Trent, A., Tirrell, M., & Olive, C. (2010) · Expert Review of Vaccines · doi:10.1586/erv.09.160 · Cited by 203
The Effects of TLR Activation on T-Cell Development and Differentiation
Jin, B., Sun, T., Yu, X.-H., Yang, Y.-X., & Yeo, A. E. T. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/836485 · Cited by 201
Mucosal Vaccine Design and Delivery
Woodrow, K. A., Bennett, K. M., & Lo, D. D. (2012) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071811-150054 · Cited by 199
Getts, D. R., Turley, D. M., Smith, C. E., Harp, C. T., McCarthy, D., Feeney, E. M., Getts, M. T., Martin, A. J., Luo, X., Terry, R. L., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1004175 · Cited by 198
Kwong, B., Gai, S. A., Elkhader, J., Wittrup, K. D., & Irvine, D. J. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3343 · Cited by 197
Self-citationYuba, E., Harada, A., Sakanishi, Y., Watarai, S., & Kono, K. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2012.12.031 · Cited by 196
Imageable Antigen‐Presenting Gold Nanoparticle Vaccines for Effective Cancer Immunotherapy In Vivo
Lee, I., Kwon, H., An, S., Kim, D., Kim, S., Yu, M. K., Lee, J., Lee, T., Im, S., & Jon, S. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201203193 · Cited by 194
Mechanistic study of the adjuvant effect of biodegradable nanoparticles in mucosal vaccination
Slütter, B., Plapied, L., Fievez, V., Alonso Sande, M., des Rieux, A., Schneider, Y.-J., Van Riet, E., Jiskoot, W., & Préat, V. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.05.011 · Cited by 192
Tang, R., Kim, C. S., Solfiell, D. J., Rana, S., Mout, R., Velázquez-Delgado, E. M., Chompoosor, A., Jeong, Y., Yan, B., Zhu, Z.-J., et al. (2013) · ACS Nano · doi:10.1021/nn402753y · Cited by 188
Nanoparticle conjugation of antigen enhances cytotoxic T-cell responses in pulmonary vaccination
Nembrini, C., Stano, A., Dane, K. Y., Ballester, M., van der Vlies, A. J., Marsland, B. J., Swartz, M. A., & Hubbell, J. A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1104264108 · Cited by 187
Li, A. V., Moon, J. J., Abraham, W., Suh, H., Elkhader, J., Seidman, M. A., Yen, M., Im, E.-J., Foley, M. H., Barouch, D. H., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006516 · Cited by 186
Self-citationvan ′t Klooster, G., Hoeben, E., Borghys, H., Looszova, A., Bouche, M.-P., van Velsen, F., & Baert, L. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01529-09 · Cited by 186
Zhu, Q., Talton, J., Zhang, G., Cunningham, T., Wang, Z., Waters, R. C., Kirk, J., Eppler, B., Klinman, D. M., Sui, Y., et al. (2012) · Nature Medicine · doi:10.1038/nm.2866 · Cited by 185
Antiviral immune responses in the genital tract: clues for vaccines
Iwasaki, A. (2010) · Nature Reviews Immunology · doi:10.1038/nri2836 · Cited by 184
Zhu, Q., Egelston, C., Vivekanandhan, A., Uematsu, S., Akira, S., Klinman, D. M., Belyakov, I. M., & Berzofsky, J. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805325105 · Cited by 183
GD3 vaccines for melanoma: superior immunogenicity of keyhole limpet hemocyanin conjugate vaccines.
Helling, F., Shang, A., Calves, M. J., Zhang, S., Ren, S., Yu, R. K., Oettgen, H. F., & Livingston, P. O. (1994) · PubMed · Cited by 179
Thornton, E. E., Looney, M. R., Bose, O., Sen, D., Sheppard, D., Locksley, R., Huang, X., & Krummel, M. F. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20112667 · Cited by 179
Bures, P., Huang, Y., Oral, E., & Peppas, N. A. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00259-0 · Cited by 178
Rational design of small molecules as vaccine adjuvants
Wu, T. Y.-H., Singh, M., Miller, A. T., De Gregorio, E., Doro, F., D’Oro, U., Skibinski, D. A. G., Mbow, M. L., Bufali, S., Herman, A. E., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009980 · Cited by 176
Kwong, B., Liu, H., & Irvine, D. J. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.03.067 · Cited by 175
Self-citationSmirnov, D., Schmidt, J. J., Capecchi, J. T., & Wightman, P. D. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.05.061 · Cited by 174
Targeted delivery of TLR ligands to human and mouse dendritic cells strongly enhances adjuvanticity
Tacken, P. J., Zeelenberg, I. S., Cruz, L. J., van Hout-Kuijer, M. A., van de Glind, G., Fokkink, R. G., Lambeck, A. J. A., & Figdor, C. G. (2011) · Blood · doi:10.1182/blood-2011-07-367615 · Cited by 173
Niu, L., Strahotin, S., Hewes, B., Zhang, B., Zhang, Y., Archer, D., Spencer, T., Dillehay, D., Kwon, B., Chen, L., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.7.4194 · Cited by 171
Ilyinskii, P. O., Roy, C. J., O’Neil, C. P., Browning, E. A., Pittet, L. A., Altreuter, D. H., Alexis, F., Tonti, E., Shi, J., Basto, P. A., et al. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.02.027 · Cited by 171
Size- and charge-dependent non-specific uptake of PEGylated nanoparticles by macrophages
Yu, S., Lau, Thomas, Jerome, Dickerson, Giorgio, T., Hubbell, & Maron (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s28531 · Cited by 171
Zhang, S., Sun, H.-J., Hughes, A. D., Moussodia, R.-O., Bertin, A., Chen, Y., Pochan, D. J., Heiney, P. A., Klein, M. L., & Percec, V. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1402858111 · Cited by 169
Cited by
Nanotechnology for Multimodal Synergistic Cancer Therapy
Fan, W., Yung, B., Huang, P., & Chen, X. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00258 · Cited by 1,791
Rethinking cancer nanotheranostics
Chen, H., Zhang, W., Zhu, G., Xie, J., & Chen, X. (2017) · Nature Reviews Materials · doi:10.1038/natrevmats.2017.24 · Cited by 1,102
Nanoparticle‐Mediated Immunogenic Cell Death Enables and Potentiates Cancer Immunotherapy
Duan, X., Chan, C., & Lin, W. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201804882 · Cited by 1,033
Concepts of nanoparticle cellular uptake, intracellular trafficking, and kinetics in nanomedicine
Donahue, N. D., Acar, H., & Wilhelm, S. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.04.008 · Cited by 944
Enhanced Cancer Immunotherapy by Microneedle Patch-Assisted Delivery of Anti-PD1 Antibody
Wang, C., Ye, Y., Hochu, G. M., Sadeghifar, H., & Gu, Z. (2016) · Nano Letters · doi:10.1021/acs.nanolett.5b05030 · Cited by 784
Metadata
- Authors
- Irvine, D. J., Hanson, M. C., Rakhra, K., & Tokatlian, T.
- Venue
- Chemical Reviews
- Publisher
- American Chemical Society (ACS)
- Published
- 2015-07-08
- Volume
- 115
- Issue
- 19
- Pages
- 11109-11146
- ISSN
- 0009-2665 (ISSN-L)
- 1520-6890
- OpenAlex
- W994417814
- Cited by
- 763
- References
- 331
- FWCI
- 4.49
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.